Overview

Safety Study of SPARC1104

Status:
Completed
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
Open-label, safety study of SPARC1104 in subjects with spasticity due to multiple sclerosis
Phase:
Phase 3
Details
Lead Sponsor:
Sun Pharma Advanced Research Company Limited